| WHO-EORTC classification for cutaneous lymphomas R Willemze, ES Jaffe, G Burg, L Cerroni, E Berti, SH Swerdlow, ... Blood 105 (10), 3768-3785, 2005 | 4885 | 2005 |
| Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic … BD Cheson, JM Bennett, KJ Kopecky, T Büchner, CL Willman, EH Estey, ... Journal of clinical oncology 21 (24), 4642-4649, 2003 | 3036 | 2003 |
| EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer R Willemze, H Kerl, W Sterry, E Berti, L Cerroni, S Chimenti, ... Blood, The Journal of the American Society of Hematology 90 (1), 354-371, 1997 | 1705 | 1997 |
| Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous … E Olsen, E Vonderheid, N Pimpinelli, R Willemze, Y Kim, R Knobler, ... Blood, The Journal of the American Society of Hematology 110 (6), 1713-1722, 2007 | 1689 | 2007 |
| The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas R Willemze, L Cerroni, W Kempf, E Berti, F Facchetti, SH Swerdlow, ... Blood, The Journal of the American Society of Hematology 133 (16), 1703-1714, 2019 | 1197 | 2019 |
| Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia RA Zittoun, F Mandelli, R Willemze, T De Witte, B Labar, L Resegotti, ... New England Journal of Medicine 332 (4), 217-223, 1995 | 1089 | 1995 |
| Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells AJ Nauta, AB Kruisselbrink, E Lurvink, R Willemze, WE Fibbe The Journal of Immunology 177 (4), 2080-2087, 2006 | 972 | 2006 |
| Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of … MW Bekkenk, FAMJ Geelen, PCV Vader, F Heule, ML Geerts, ... Blood, The Journal of the American Society of Hematology 95 (12), 3653-3661, 2000 | 953 | 2000 |
| Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation PS int Anker, SA Scherjon, C Kleijburg-Van der Keur, WA Noort, ... Blood 102 (4), 1548-1549, 2003 | 897 | 2003 |
| Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting AJ Nauta, G Westerhuis, AB Kruisselbrink, EGA Lurvink, R Willemze, ... Blood 108 (6), 2114-2120, 2006 | 879 | 2006 |
| Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases R Willemze, PM Jansen, L Cerroni, E Berti, M Santucci, C Assaf, ... Blood, The Journal of the American Society of Hematology 111 (2), 838-845, 2008 | 740 | 2008 |
| WHO classification of skin tumours DE Elder, D Massi, RA Scolyer, R Willemze (No Title), 2018 | 678 | 2018 |
| Mesenchymal stem cells promote engraftment of human umbilical cord blood–derived CD34+ cells in NOD/SCID mice WA Noort, AB Kruisselbrink, PS in't Anker, M Kruger, RL van Bezooijen, ... Experimental hematology 30 (8), 870-878, 2002 | 668 | 2002 |
| Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United … EA Olsen, S Whittaker, YH Kim, M Duvic, HM Prince, SR Lessin, GS Wood, ... Journal of Clinical Oncology 29 (18), 2598, 2011 | 666 | 2011 |
| Molecular Remission in PML/RARα-Positive Acute Promyelocytic Leukemia by Combined All-trans Retinoic Acid and Idarubicin (AIDA) Therapy F Mandelli, D Diverio, G Avvisati, A Luciano, T Barbui, C Bernasconi, ... Blood, The Journal of the American Society of Hematology 90 (3), 1014-1021, 1997 | 646 | 1997 |
| Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1 AJM Ferreri, E Campo, JF Seymour, R Willemze, F Ilariucci, A Ambrosetti, ... British journal of haematology 127 (2), 173-183, 2004 | 643 | 2004 |
| Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas EC Vonderheid, MG Bernengo, G Burg, M Duvic, P Heald, L Laroche, ... Journal of the American Academy of Dermatology 46 (1), 95-106, 2002 | 617 | 2002 |
| Hematopoiesis-restricted minor histocompatibility antigens HA-1-or HA-2-specific T cells can induce complete remissions of relapsed leukemia WAE Marijt, MHM Heemskerk, FM Kloosterboer, E Goulmy, MGD Kester, ... Proceedings of the National Academy of Sciences 100 (5), 2742-2747, 2003 | 561 | 2003 |
| EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome F Trautinger, R Knobler, R Willemze, K Peris, R Stadler, L Laroche, ... European journal of cancer 42 (8), 1014-1030, 2006 | 556 | 2006 |
| TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas … YH Kim, R Willemze, N Pimpinelli, S Whittaker, EA Olsen, A Ranki, ... Blood, The Journal of the American Society of Hematology 110 (2), 479-484, 2007 | 537 | 2007 |
